Curriculum
18 Sections
99 Lessons
6 Weeks
Expand all sections
Collapse all sections
Module 1: Foundations of Obesity as a Chronic Metabolic Disease
6
18.1
Epidemiology and Global Burden of Obesity
18.2
Energy Balance and Regulation of Body Weight
18.3
Neurohormonal Regulation of Appetite and Satiety
18.4
Inflammation, Insulin Resistance, and Adipose Biology
18.5
Metabolic Adaptation and Set-Point Theory
18.6
Obesity Phenotypes and Clinical Staging
Module 2: Clinical Evaluation of the Obesity Patient
5
19.1
Comprehensive Obesity-Focused History
19.2
Anthropometry and Body Composition Assessment
19.3
Laboratory Evaluation and Metabolic Screening
19.4
Identification of Secondary Causes of Obesity
19.5
Cardiometabolic Risk Stratification
Module 3: Clinical Nutrition in Obesity Practice
9
20.1
Macronutrient Science in Obesity
20.2
Protein Requirements and Muscle Preservation
20.3
Carbohydrate Quality, Glycemic Load, and Insulin Response
20.4
Dietary Fat, Fiber, and the Gut Microbiome
20.5
Low-Carbohydrate, Mediterranean, and Balanced Diet Models
20.6
Nutrition Planning During GLP-1 Therapy
20.7
Sarcopenic Obesity and Body Composition–Focused Nutrition
20.8
Micronutrients and Supplementation in Obesity
20.9
Cultural and Vegetarian Diet Adaptations
Module 4: Exercise and Physical Activity Prescription
5
21.1
Exercise Physiology in Obesity
21.2
Resistance Training for Fat Loss and Muscle Preservation
21.3
Aerobic Training and HIIT Protocols
21.4
Exercise Prescription in Special Populations
21.5
Exercise in Insulin Resistance and Metabolic Syndrome
Module 5: Behavioural Medicine and Patient Support
6
22.1
Obesity Stigma and Bias in Healthcare
22.2
Foundations of Motivational Interviewing
22.3
Advanced Behaviour Change Techniques
22.4
Neurobiology of Cravings and Habit Loops
22.5
Emotional Eating and Stress-Related Eating
22.6
Relapse Prevention and Long-Term Adherence
Module 6: GLP-1 Physiology and Mechanisms
4
23.1
Incretin Physiology and the Gut–Brain Axis
23.2
GLP-1 Receptor Signalling Pathways
23.3
Effects on Appetite, Gastric Emptying, and Satiety
23.4
Central Nervous System and Metabolic Effects
Module 7: GLP-1 Receptor Agonists and Dual Agonists – Clinical Overview
6
24.1
Liraglutide in Obesity and Diabetes
24.2
Semaglutide in Weight Management
24.3
Tirzepatide and Dual GIP/GLP-1 Agonism
24.4
Comparative Efficacy and Safety Profiles
24.5
Cardiovascular and Renal Outcome Evidence
24.6
Emerging Incretin-Based Therapies
Module 8: Weight Loss Outcomes and Glycaemic Improvements
6
25.1
Evidence from Major Obesity Clinical Trials
25.2
Body Composition and Visceral Fat Reduction
25.3
HbA1c Reduction and Insulin Resistance Improvement
25.4
Cardiovascular Risk Reduction
25.5
Predictors of Therapeutic Response
25.6
Understanding Weight Loss Plateaus
Module 9: Pharmacotherapy in Obesity
5
26.1
Indications and Guidelines for Anti-Obesity Medications
26.2
Non-GLP-1 Pharmacological Options
26.3
Combination Pharmacotherapy Strategies
26.4
Choosing Therapy Based on Patient Phenotype
26.5
Integration of Pharmacotherapy with Nutrition and Exercise
Module 10: Drug Dosing and Titration in Obesity Pharmacotherapy
6
27.1
Initiation Protocols for GLP-1 Receptor Agonists
27.2
Stepwise Dose Escalation Strategies
27.3
Dosing in Patients with Type 2 Diabetes
27.4
Combination Therapy Titration
27.5
Dose Optimization and Plateau Management
27.6
De-escalation and Transition Planning
Module 11: Safety Monitoring and Adverse Effect Management
5
28.1
Gastrointestinal Adverse Effects and Mitigation
28.2
Pancreatitis and Gallbladder Risk Monitoring
28.3
Thyroid and Endocrine Safety Considerations
28.4
Renal and Hepatic Considerations
28.5
Perioperative and Special Scenario Management
Module 12: Obesity-Linked Metabolic Disorders
6
29.1
Obesity and Type 2 Diabetes (Diabesity Management)
29.2
Insulin De-Intensification Strategies
29.3
Obesity and Polycystic Ovary Syndrome
29.4
Obesity and MASLD (Metabolic Fatty Liver Disease)
29.5
Obesity and Cardiovascular Disease
29.6
Obesity in Chronic Kidney Disease
Module 13: Special Populations in Obesity Medicine
5
30.1
Adolescent Obesity
30.2
Obesity in the Elderly
30.3
Obesity and Pregnancy Planning
30.4
Sarcopenic Obesity
30.5
Resistant and Complex Obesity
Module 14: Bariatric and Metabolic Surgery – Role of the Physician
5
31.1
Indications and Overview of Procedures
31.2
Pre-operative Medical Optimization
31.3
Post-operative Nutritional Monitoring
31.4
Pharmacotherapy After Bariatric Surgery
31.5
Managing Post-Surgical Weight Regain
Module 15: Long-Term Follow-Up and Weight Maintenance
5
32.1
Physiology of Weight Regain
32.2
Maintenance Pharmacotherapy Strategies
32.3
Structured Follow-Up and Monitoring Protocols
32.4
Transitioning Off GLP-1 Therapy
32.5
Sustainable Long-Term Lifestyle Integration
Module 16: Practice Integration for Busy Clinicians
5
33.1
Designing an Obesity-Focused Clinical Workflow
33.2
Structured Consultation Templates
33.3
Team-Based Care Models
33.4
Documentation and Follow-Up Systems
33.5
Digital Monitoring and Remote Care Integration
Module 17: Case Discussions and Logbook
5
34.1
Structured Obesity Consultation Cases
34.2
GLP-1 Titration Case Scenarios
34.3
PCOS, Diabetes, and MASLD Case Management
34.4
Resistant and Complex Obesity Cases
34.5
Logbook Submission and Clinical Audit
Module 18: Final Assessment and Certification
5
35.1
MCQ Examination
35.2
Case-Based OSCE
35.3
Prescription Writing Assessment
35.4
Viva on Pharmacotherapy, Nutrition, and Safety
35.5
Certification Award
Fellowship in Obesity Management
Search
This content is protected, please
login
and enroll in the course to view this content!
WhatsApp us
Home
Courses
Search
Search
Account
Login with your site account
Lost your password?
Remember Me
Modal title
Main Content